Business Information
The group's principal activities are to develop, manufacture and distribute generic drugs and complex synthetic active pharmaceutical ingredients in the United States. The products are in the form of tablet, capsules, and semi-solid and two-piece hard shell capsule. Generic drug consists of 170 products representing various dosage strengths for 71 separate drugs. The group markets its products to wholesalers, retail drug store chains, managed health care providers, clinics, governmental agencies, health care organizations and drug distributors.
|
|
Name |
Title
|
Email
|
| Patrick Lepore | Dir., Chmn., CEO, Pres. | N/A | | Gerard Martino | COO, Exec. VP | N/A | | John MacPhee | Exec. VP, Pres. - Branded Products Division | Available | | Paul Campanelli | Exec. VP, Pres. - Generics Division | Available | | Thomas Haughey | Exec. VP, General Counsel, Corp. Sec. | Available
|
|
|
Year |
Sales |
Net Income |
| 2005 | 432,256 | (15,309) | | 2004 | 690,016 | 29,246 | | 2003 | 661,688 | 122,533
|
|
| TO SEE COMPLETE RESULTS SUBSCRIBE NOW |
TO SEE COMPLETE RESULTS SUBSCRIBE NOW |
|
Click for more Executives |
|
|
